Atogepant proved effective, safe, and well-tolerated in refractory high-frequency episodic migraine and chronic migraine, ...

In a new study, Ubrelvy provided relief for people who took it as soon as they noticed early migraine symptoms like light ...

Trial to be conducted by Dr. Hyon Choi at Massachusetts General Hospital and will compare the safety and efficacy of two dose ...